Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential.
暂无分享,去创建一个
R. Moreau | T. Hagen | Tory M Hagen | Eric J. Smith | Kate Petersen Shay | Régis F Moreau | Eric J Smith | Anthony R Smith | Anthony R. W. Smith | K. Shay
[1] J. M. May,et al. Uptake, recycling, and antioxidant actions of alpha-lipoic acid in endothelial cells. , 2002, Free radical biology & medicine.
[2] L. Packer,et al. The plasma pharmacokinetics of R-(+)-lipoic acid administered as sodium R-(+)-lipoate to healthy human subjects. , 2007, Alternative medicine review : a journal of clinical therapeutic.
[3] F. Cheema,et al. Irbesartan and Lipoic Acid Improve Endothelial Function and Reduce Markers of Inflammation in the Metabolic Syndrome: Results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) Study , 2005, Circulation.
[4] B. Ames,et al. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: Partial reversal by feeding acetyl-l-carnitine and/or R-α-lipoic acid , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[5] S. Jacob,et al. Stimulation by alpha-lipoic acid of glucose transport activity in skeletal muscle of lean and obese Zucker rats. , 1997, Life sciences.
[6] E. Harrison,et al. The metabolism of dl-(1,6-14C)lipoic acid in the rat. , 1974, Archives of biochemistry and biophysics.
[7] B. Ames,et al. (R)-α-Lipoic Acid Reverses the Age-Associated Increase in Susceptibility of Hepatocytes to tert-Butylhydroperoxide both In Vitro and In Vivo , 2000 .
[8] U. Çakatay,et al. Prooxidant activities of alpha-lipoic acid on oxidative protein damage in the aging rat heart muscle. , 2005, Archives of gerontology and geriatrics.
[9] D. Leroith,et al. A Molecular Basis for Insulin Resistance , 1997, The Journal of Biological Chemistry.
[10] O. Lorenzo,et al. Differential redox regulation within the PTP superfamily. , 2007, Cellular signalling.
[11] K. Kraemer,et al. Molecular aspects of lipoic acid in the prevention of diabetes complications. , 2001, Nutrition.
[12] R. Cole,et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[13] R. Hermann,et al. Plasma Kinetics, Metabolism, and Urinary Excretion of Alpha‐Lipoic Acid following Oral Administration in Healthy Volunteers , 2003, Journal of clinical pharmacology.
[14] D. Sanadi,et al. alpha-Ketoglutaric dehydrogenase. 8. Isolation and some properties of a flavoprotein compnent. , 1960, The Journal of biological chemistry.
[15] E. Chan,et al. Distribution study of orally administered lipoic acid in rat brain tissues , 2009, Brain Research.
[16] W. Müller,et al. The potent free radical scavenger α-lipoic acid improves memory in aged mice: Putative relationship to NMDA receptor deficits , 1993, Pharmacology, Biochemistry and Behavior.
[17] L. Packer,et al. Antioxidant activities of dihydrolipoic acid and its structural homologues. , 1993, Free radical research communications.
[18] S. Jacob,et al. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. , 1999, Free radical biology & medicine.
[19] M. Shimizu,et al. Transepithelial Transport of α-Lipoic Acid across Human Intestinal Caco-2 Cell Monolayers , 2007 .
[20] Jiankang Liu,et al. (R)-alpha-lipoic acid reverses the age-related loss in GSH redox status in post-mitotic tissues: evidence for increased cysteine requirement for GSH synthesis. , 2004, Archives of biochemistry and biophysics.
[21] B. C. Scott,et al. Lipoic and dihydrolipoic acids as antioxidants. A critical evaluation. , 1994, Free radical research.
[22] V. Ravindranath,et al. alpha-Lipoic acid protects against reperfusion injury following cerebral ischemia in rats. , 1996, Brain research.
[23] A. Bast,et al. Interplay between lipoic acid and glutathione in the protection against microsomal lipid peroxidation. , 1988, Biochimica et biophysica acta.
[24] Takafumi Suzuki,et al. Physiological Significance of Reactive Cysteine Residues of Keap1 in Determining Nrf2 Activity , 2008, Molecular and Cellular Biology.
[25] R. Moreau,et al. Is α‐lipoic acid a scavenger of reactive oxygen species in vivo? Evidence for its initiation of stress signaling pathways that promote endogenous antioxidant capacity , 2008, IUBMB life.
[26] H. Tritschler,et al. α-Lipoic acid reduces expression of vascular cell adhesion molecule-1 and endothelial adhesion of human monocytes after stimulation with advanced glycation end products , 1999 .
[27] D. Cremer,et al. Long-term safety of alpha-lipoic acid (ALA) consumption: A 2-year study. , 2006, Regulatory toxicology and pharmacology : RTP.
[28] T. Meinertz,et al. Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress. , 2001, Free radical biology & medicine.
[29] S. Jacob,et al. The antioxidant alpha-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. , 1996, Diabetes.
[30] T. Hagen,et al. Age-related decline of sodium-dependent ascorbic acid transport in isolated rat hepatocytes. , 2003, Archives of biochemistry and biophysics.
[31] B. Ames,et al. Age‐associated decline in ascorbic acid concentration, recycling, and biosynthesis in rat hepatocytes—reversal with (R)‐α‐lipoic acid supplementation , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] D. Bourdette,et al. Lipoic acid inhibits expression of ICAM-1 and VCAM-1 by CNS endothelial cells and T cell migration into the spinal cord in experimental autoimmune encephalomyelitis , 2006, Journal of Neuroimmunology.
[33] H. Tritschler,et al. Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant? , 1995, Biochemical pharmacology.
[34] D. Butterfield,et al. The antioxidants α‐lipoic acid and N‐acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice , 2003, Journal of neurochemistry.
[35] Shenmin Zhang,et al. A modified cysteinyl-labeling assay reveals reversible oxidation of protein tyrosine phosphatases in angiomyolipoma cells , 2008, Proceedings of the National Academy of Sciences.
[36] R. Hermann,et al. Dose-proportionality of oral thioctic acid--coincidence of assessments via pooled plasma and individual data. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[37] L. Packer,et al. R-alpha-lipoic acid action on cell redox status, the insulin receptor, and glucose uptake in 3T3-L1 adipocytes. , 2002, Archives of biochemistry and biophysics.
[38] L. Packer,et al. α-Lipoic acid decreases thiol reactivity of the insulin receptor and protein tyrosine phosphatase 1B in 3T3-L1 adipocytes , 2003 .
[39] J. Park,et al. α-Lipoic acid inhibits matrix metalloproteinase-9 expression by inhibiting NF-κB transcriptional activity , 2007, Experimental & Molecular Medicine.
[40] R. Somwar,et al. The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation. , 2001, Diabetes.
[41] R. Fernandes,et al. Effects of alpha-lipoic acid on endothelial function in aged diabetic and high-fat fed rats. , 2008, British journal of pharmacology.
[42] A. Bush. Metal complexing agents as therapies for Alzheimer’s disease , 2002, Neurobiology of Aging.
[43] D. Hardie,et al. 5′-AMP-activated Protein Kinase Phosphorylates IRS-1 on Ser-789 in Mouse C2C12 Myotubes in Response to 5-Aminoimidazole-4-carboxamide Riboside* , 2001, The Journal of Biological Chemistry.
[44] A. Bast,et al. Scavenging of hypochlorous acid by lipoic acid. , 1991, Biochemical pharmacology.
[45] Daniel C Liebler,et al. Specific Patterns of Electrophile Adduction Trigger Keap1 Ubiquitination and Nrf2 Activation* , 2005, Journal of Biological Chemistry.
[46] J. Keaney,et al. Effect of Combined Treatment With α‐Lipoic Acid and Acetyl‐L‐Carnitine on Vascular Function and Blood Pressure in Patients With Coronary Artery Disease , 2007 .
[47] D. Tomassoni,et al. Pharmacokinetics of Different Formulations of Tioctic (Alpha-Lipoic) Acid in Healthy Volunteers , 2008, Clinical and experimental hypertension.
[48] C. B. Pickett,et al. Phosphorylation of Nrf2 at Ser-40 by Protein Kinase C Regulates Antioxidant Response Element-mediated Transcription* , 2002, The Journal of Biological Chemistry.
[49] A Bast,et al. The pharmacology of the antioxidant lipoic acid. , 1997, General pharmacology.
[50] W. Woodward,et al. Lipoic acid in multiple sclerosis: a pilot study , 2005, Multiple sclerosis.
[51] B. Viollet,et al. Anti-obesity effects of α-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase , 2004, Nature Medicine.
[52] C. Sen,et al. Protection against glutamate-induced cytotoxicity in C6 glial cells by thiol antioxidants. , 1997, American journal of physiology. Regulatory, integrative and comparative physiology.
[53] H. Sies,et al. Prevention of singlet oxygen-induced DNA damage by lipoate. , 1993, Chemico-biological interactions.
[54] J. Wojtaszewski,et al. Role of Akt substrate of 160 kDa in insulin-stimulated and contraction-stimulated glucose transport. , 2007, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.
[55] H. Tritschler,et al. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy. , 1999, Free radical research.
[56] U. Çakatay,et al. Effect of alpha‐lipoic acid supplementation on markers of protein oxidation in post‐mitotic tissues of ageing rat , 2006, Cell biochemistry and function.
[57] C. Sen,et al. Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization , 1997, BioFactors.
[58] V. Ravindranath,et al. α-Lipoic acid protects against reperfusion injury following cerebral ischemia in rats , 1996, Brain Research.
[59] A. Kong,et al. Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2 , 2006, Molecular Cancer Therapeutics.
[60] A. Klip,et al. Stimulation of Glucose Uptake by the Natural Coenzyme α-Lipoic Acid/Thioctic Acid: Participation of Elements of the Insulin Signaling Pathway , 1996, Diabetes.
[61] S. Vasdev,et al. Salt-induced hypertension in WKY rats: Prevention by α-lipoic acid supplementation , 2003, Molecular and Cellular Biochemistry.
[62] Su-Jane Wang,et al. Presynaptic mechanisms underlying the α-lipoic acid facilitation of glutamate exocytosis in rat cerebral cortex nerve terminals , 2007, Neurochemistry International.
[63] U. Henning. Multienzyme complexes. , 1966, Angewandte Chemie.
[64] Takahiro Shibata,et al. Oxidative and Electrophilic Stresses Activate Nrf2 through Inhibition of Ubiquitination Activity of Keap1 , 2006, Molecular and Cellular Biology.
[65] M. Hanefeld,et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). , 1995, Diabetologia.
[66] P. Di Mascio,et al. Singlet oxygen induced single-strand breaks in plasmid pBR322 DNA: the enhancing effect of thiols. , 1991, Biochimica et biophysica acta.
[67] Wei-jian Zhang,et al. α‐Lipoic acid inhibits TNF‐a‐induced NF‐κB activation and adhesion molecule expression in human aortic endothelial cells , 2001 .
[68] N. Vaziri,et al. Biotin uptake by human proximal tubular epithelial cells: cellular and molecular aspects. , 2005, American journal of physiology. Renal physiology.
[69] Woojin Jeong,et al. Reversible Inactivation of the Tumor Suppressor PTEN by H2O2 * , 2002, The Journal of Biological Chemistry.
[70] A. Bast,et al. Lipoic acid: A multifunctional antioxidant , 2003, BioFactors.
[71] J. de Champlain,et al. Prevention of Hypertension, Insulin Resistance, and Oxidative Stress by &agr;-Lipoic Acid , 2002, Hypertension.
[72] Mark Hannink,et al. Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex , 2004, Molecular and Cellular Biology.
[73] T. Foley,et al. Oxidative Inhibition of Protein Phosphatase 2A Activity: Role of Catalytic Subunit Disulfides , 2007, Neurochemical Research.
[74] F. Gries,et al. Effects of Treatment With the Antioxidant α-Lipoic Acid on Cardiac Autonomic Neuropathy in NIDDM Patients: A 4-month randomized controlled multicenter trial (DEKAN Study) , 1997, Diabetes Care.
[75] T. Silhavy,et al. Lipoic Acid Metabolism in Escherichia coli : Isolation of Null Mutants Defective in Lipoic Acid Biosynthesis , Molecular Cloning and Characterization of the E . coli lip Locus , and Identification of the Lipoylated Protein of the Glycine Cleavage System , 2005 .
[76] U. Munzel,et al. Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy , 2006, Diabetes Care.
[77] Jun Ren,et al. Ca2+/calmodulin-dependent protein kinase kinase is involved in AMP-activated protein kinase activation by alpha-lipoic acid in C2C12 myotubes. , 2007, American journal of physiology. Cell physiology.
[78] I. Leconte,et al. Molecular basis of insulin resistance. , 1992, Hormone research.
[79] S. Jacob,et al. Stimulation by α-lipoic acid of glucose transport activity in skeletal muscle of lean and obese Zucker rats , 1997 .
[80] D. Cremer,et al. Safety evaluation of α-lipoic acid (ALA) , 2006 .
[81] H. Tritschler,et al. Effects of 3‐week oral treatment with the antioxidant thioctic acid (α‐lipoic acid) in symptomatic diabetic polyneuropathy , 1999, Diabetic medicine : a journal of the British Diabetic Association.
[82] M. Louhelainen,et al. Lipoic acid supplementation prevents cyclosporine-induced hypertension and nephrotoxicity in spontaneously hypertensive rats , 2006, Journal of hypertension.
[83] S. Jacob,et al. Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. , 1995, Arzneimittel-Forschung.
[84] B. Kornhuber,et al. Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo. , 1992, Arzneimittel-Forschung.
[85] V. Ganapathy,et al. Cloning and Functional Expression of a cDNA Encoding a Mammalian Sodium-dependent Vitamin Transporter Mediating the Uptake of Pantothenate, Biotin, and Lipoate* , 1998, The Journal of Biological Chemistry.
[86] U. Ikeda,et al. Interleukin‐6 and acute coronary syndrome , 2001, Clinical cardiology.
[87] T. Hagen,et al. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[88] John M Pezzuto,et al. Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[89] J. Morrow,et al. Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)‐α‐lipoic acid , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[90] P. Jones,et al. Alpha-lipoic acid and cardiovascular disease. , 2003, The Journal of nutrition.
[91] W. Zhang,et al. Alpha-lipoic acid inhibits TNF-alpha-induced NF-kappaB activation and adhesion molecule expression in human aortic endothelial cells. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[92] B. Viollet,et al. AMPK-Mediated AS160 Phosphorylation in Skeletal Muscle Is Dependent on AMPK Catalytic and Regulatory Subunits , 2006, Diabetes.
[93] T. Hagen,et al. Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by alpha-lipoic acid through PI3 kinase, PTEN, and PP2A , 2009, Biogerontology.
[94] E. Henriksen,et al. Interactions of exercise training and alpha-lipoic acid on insulin signaling in skeletal muscle of obese Zucker rats. , 2004, American journal of physiology. Endocrinology and metabolism.
[95] R. Moreau,et al. Mitochondrial Decay in the Aging Rat Heart , 2002 .
[96] D. Tomassoni,et al. Comparative Crossover, Randomized, Open-Label Bioequivalence Study on the Bioequivalence of Two Formulations of Thioctic Acid in Healthy Volunteers , 2007, Clinical and experimental hypertension.
[97] J. Krieglstein,et al. Neuroprotective effects of α-lipoic acid and its enantiomers demonstrated in rodent models of focal cerebral ischemia , 1996, Neuropharmacology.
[98] C. Cobelli,et al. alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. , 1999, Diabetes care.
[99] M. Mcgahan,et al. Alpha lipoic acid changes iron uptake and storage in lens epithelial cells. , 2003, Experimental eye research.
[100] P. O'Brien,et al. The Sensory Symptoms of Diabetic Polyneuropathy Are Improved With α-Lipoic Acid , 2003 .
[101] Lingyun Wu,et al. Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production. , 2003, American journal of hypertension.
[102] M. Takaoka,et al. Effects of α-lipoic acid on deoxycorticosterone acetate–salt-induced hypertension in rats , 2001 .
[103] S. Jacob,et al. Differential effects of lipoic acid stereoisomers on glucose metabolism in insulin-resistant skeletal muscle. , 1997, The American journal of physiology.
[104] S. Vasdev,et al. Dietary lipoic acid supplementation prevents fructose-induced hypertension in rats. , 2000, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[105] S. Vasdev,et al. Dietary α‐lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats , 2000 .
[106] L. Packer,et al. Efficacy of hypochlorous acid scavengers in the prevention of protein carbonyl formation. , 1996, Archives of biochemistry and biophysics.
[107] Kyung-Ja Cho,et al. Alpha-lipoic acid suppresses the development of collagen-induced arthritis and protects against bone destruction in mice , 2006, Rheumatology International.
[108] F. Gries,et al. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. , 1997, Diabetes care.
[109] C. Sen,et al. Fas mediated apoptosis of human Jurkat T-cells: intracellular events and potentiation by redox-active α-lipoic acid , 1999, Cell Death and Differentiation.
[110] A. Bast,et al. A method for measuring nitric oxide radical scavenging activity. Scavenging properties of sulfur–containing compounds. , 1997, Pharmacy World and Science.
[111] A. Bernkop‐Schnürch,et al. Development of a Sustained Release Dosage Form for α‐Lipoic Acid. II. Evaluation in Human Volunteers , 2004, Drug development and industrial pharmacy.
[112] D. Bourdette,et al. Lipoic acid downmodulates CD4 from human T lymphocytes by dissociation of p56(Lck). , 2006, Biochemical and biophysical research communications.
[113] T. Kronbach,et al. New metabolic pathways of alpha-lipoic acid. , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[114] H. Tritschler,et al. Alpha-lipoic acid reduces expression of vascular cell adhesion molecule-1 and endothelial adhesion of human monocytes after stimulation with advanced glycation end products. , 1999, Clinical science.
[115] L. Packer,et al. Thiol chelation of Cu2+ by dihydrolipoic acid prevents human low density lipoprotein peroxidation. , 1998, Free radical biology & medicine.
[116] J. Park,et al. α-Lipoic acid inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma , 2004 .
[117] L. Packer,et al. alpha-Lipoic acid as a biological antioxidant. , 1995, Free radical biology & medicine.
[118] Wei-jian Zhang,et al. Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway. , 2007, Proceedings of the National Academy of Sciences of the United States of America.
[119] P. Varalakshmi,et al. Protective role of DL-alpha-lipoic acid against mercury-induced neural lipid peroxidation. , 1999, Pharmacological research.
[120] Wei-jian Zhang,et al. α-Lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway , 2007, Proceedings of the National Academy of Sciences.
[121] J. Trevithick,et al. Modelling cortical cataractogenesis XX. In vitro effect of α‐lipoic acid on glutathione concentrations in lens in model diabetic cataractogenesis , 1998, Biochemistry and molecular biology international.
[122] L. Roccatagliata,et al. Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. , 2004, Journal of neuroimmunology.
[123] M. Hanefeld,et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipoic acid , 1995, Diabetologia.
[124] L. Packer,et al. Dihydrolipoic acid--a universal antioxidant both in the membrane and in the aqueous phase. Reduction of peroxyl, ascorbyl and chromanoxyl radicals. , 1992, Biochemical pharmacology.
[125] Min-Seon Kim,et al. Alpha-lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase. , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[126] D. Leroith,et al. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. , 2009, The Journal of biological chemistry.
[127] D. Noonan,et al. Biological assays and genomic analysis reveal lipoic acid modulation of endothelial cell behavior and gene expression. , 2006, Carcinogenesis.
[128] S. Vasdev,et al. Dietary alpha-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats. , 2000, Journal of hypertension.
[129] L. Packer,et al. Assay of protein-bound lipoic acid in tissues by a new enzymatic method. , 1998, Analytical biochemistry.
[130] M. Trujillo,et al. Peroxynitrite reaction with the reduced and the oxidized forms of lipoic acid: new insights into the reaction of peroxynitrite with thiols. , 2002, Archives of biochemistry and biophysics.
[131] A. Vollmar,et al. Alpha-lipoic acid as a directly binding activator of the insulin receptor: protection from hepatocyte apoptosis. , 2007, Biochemistry.
[132] T. Hagen,et al. Vascular endothelial dysfunction in aging: loss of Akt-dependent endothelial nitric oxide synthase phosphorylation and partial restoration by (R)-alpha-lipoic acid. , 2003, Biochemical Society transactions.
[133] J. Cronan,et al. Lipoic acid metabolism in Escherichia coli: isolation of null mutants defective in lipoic acid biosynthesis, molecular cloning and characterization of the E. coli lip locus, and identification of the lipoylated protein of the glycine cleavage system , 1991, Journal of bacteriology.
[134] U. Çakatay,et al. Postmitotic tissue selenium and manganese levels in alpha-lipoic acid-supplemented aged rats. , 2008, Chemico-Biological Interactions.
[135] R. Hermann,et al. Pharmacokinetics of Alpha‐Lipoic Acid in Subjects With Severe Kidney Damage and End‐Stage Renal Disease , 2005, Journal of clinical pharmacology.
[136] L. Packer,et al. Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species. , 1991, Free radical research communications.
[137] J. Krieglstein,et al. Neuroprotective effects of alpha-lipoic acid and its enantiomers demonstrated in rodent models of focal cerebral ischemia. , 1996, Neuropharmacology.
[138] C. Downes,et al. Multiple roles of phosphatidylinositol 3-kinase in regulation of glucose transport, amino acid transport, and glucose transporters in L6 skeletal muscle cells. , 1995, Endocrinology.
[139] R. Somwar,et al. Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by α-lipoic acid in 3T3-L1 adipocytes , 2000, Diabetologia.
[140] L. Packer,et al. R-α-Lipoic Acid Action on Cell Redox Status, the Insulin Receptor, and Glucose Uptake in 3T3-L1 Adipocytes , 2002 .
[141] D. Liebler,et al. Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3. , 2008, Chemical research in toxicology.
[142] R. Moreau,et al. Mitochondrial decay in the aging rat heart: evidence for improvement by dietary supplementation with acetyl-L-carnitine and/or lipoic acid. , 2002, Annals of the New York Academy of Sciences.
[143] D. Bourdette,et al. Lipoic acid stimulates cAMP production in T lymphocytes and NK cells. , 2007, Biochemical and biophysical research communications.
[144] P. O'Brien,et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. , 2003, Diabetes care.
[145] D. Cremer,et al. Safety evaluation of alpha-lipoic acid (ALA). , 2006, Regulatory toxicology and pharmacology : RTP.
[146] S. Vasdev,et al. Salt-induced hypertension in WKY rats: prevention by alpha-lipoic acid supplementation. , 2003, Molecular and cellular biochemistry.
[147] J. Blumberg,et al. Differential Regulation of MAP Kinase Signaling by Pro‐ and Antioxidant Biothiols , 2000, Annals of the New York Academy of Sciences.
[148] B. Halliwell,et al. alpha-Lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria. , 1999, Free radical biology & medicine.
[149] R. Wolfe,et al. Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. , 1993, The American journal of physiology.
[150] M. Widlansky,et al. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. , 2004, Current medicinal chemistry.
[151] H. Huang,et al. Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[152] Min-Seon Kim,et al. Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. , 2005, Biochemical and biophysical research communications.
[153] H. Tritschler,et al. Investigations on the pharmacokinetics of alpha-lipoic acid in healthy volunteers. , 1998, International journal of clinical pharmacology and therapeutics.
[154] D. Cremer,et al. Long-term safety of α-lipoic acid (ALA) consumption: A 2-year study , 2006 .
[155] A. Bast,et al. Reduction of lipoic acid by lipoamide dehydrogenase. , 1996, Biochemical pharmacology.
[156] U. Çakatay,et al. Plasma protein oxidation in aging rats after alpha-lipoic acid administration , 2005, Biogerontology.
[157] B. Ames,et al. (R)-alpha-lipoic acid reverses the age-associated increase in susceptibility of hepatocytes to tert-butylhydroperoxide both in vitro and in vivo. , 2000, Antioxidants & redox signaling.
[158] G. Sesti,et al. Insulin-Dependent Activation of Endothelial Nitric Oxide Synthase Is Impaired by O-Linked Glycosylation Modification of Signaling Proteins in Human Coronary Endothelial Cells , 2002, Circulation.
[159] S. Rhee,et al. Reversible Inactivation of Protein-tyrosine Phosphatase 1B in A431 Cells Stimulated with Epidermal Growth Factor* , 1998, The Journal of Biological Chemistry.
[160] P. Low,et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant α‐lipoic acid: a meta‐analysis , 2004, Diabetic medicine : a journal of the British Diabetic Association.
[161] M. Hanefeld,et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. , 1999, Diabetes care.
[162] J. Blumberg,et al. Homocysteine and α-Lipoic Acid Regulate p44/42 MAP Kinase Phosphorylation in NIH/3T3 Cells , 1999 .
[163] J. M. May,et al. Uptake, recycling, and antioxidant actions of α-lipoic acid in endothelial cells , 2002 .
[164] M. Christopher,et al. Lipoic acid is 10 times more toxic in cats than reported in humans, dogs or rats. , 2004, Journal of animal physiology and animal nutrition.
[165] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[166] T. Kronbach,et al. New Metabolic Pathways of α-Lipoic Acid , 2001 .
[167] L. Roccatagliata,et al. α-Lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis , 2004, Journal of Neuroimmunology.
[168] P. Arivazhagan,et al. Effect of DL-α-lipoic acid on the status of lipid peroxidation and antioxidant enzymes in various brain regions of aged rats , 2002, Experimental Gerontology.
[169] S. Jacob,et al. The Antioxidant α-Lipoic Acid Enhances Insulin-Stimulated Glucose Metabolism in Insulin-Resistant Rat Skeletal Muscle , 1996, Diabetes.
[170] L. Goodyear,et al. Contraction signaling to glucose transport in skeletal muscle. , 2005, Journal of applied physiology.
[171] R. Fernandes,et al. Effects of α‐lipoic acid on endothelial function in aged diabetic and high‐fat fed rats , 2008 .
[172] Min-Seon Kim,et al. α-Lipoic Acid Prevents Endothelial Dysfunction in Obese Rats via Activation of AMP-Activated Protein Kinase , 2005 .
[173] Hui Chen,et al. Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells. , 2002, Molecular endocrinology.
[174] R. Moreau,et al. Dietary supplementation with (R)-α-lipoic acid reverses the age-related accumulation of iron and depletion of antioxidants in the rat cerebral cortex , 2005, Redox report : communications in free radical research.
[175] S. Vasdev,et al. Dietary lipoic acid supplementation attenuates hypertension in Dahl salt sensitive rats , 2005, Molecular and Cellular Biochemistry.